Archive for May 2018

Charles Hamilton is a director and member of the Piper Jaffray healthcare investment banking team, focusing on medical technology companies. Hamilton has 14 years of healthcare investment banking and capital markets experience. He has advised public and private clients through a broad range of investment banking services, including sell-side and buy-side mergers and acquisitions as…

Badrul A. Chowdhury is Senior Vice President and Head Respiratory, Inflammation and Autoimmunity at MedImmune. He was previously the Director, Division of Pulmonary, Allergy, and Rheumatology Products, Center for Drug Evaluation and Research at the US FDA. While at the FDA, Dr. Chowdhury provided scientific and regulatory oversight of medicines in highly prevalent diseases, such…

Anthony Flores is a Managing Director and the Head of Southwest Life Sciences & Healthcare within Silicon Valley Bank’s National Life Science Division. He joined Silicon Valley Bank (SVB) in 2012 and oversees a client portfolio comprised of the over 300 of the region’s top life science & healthcare companies. Anthony and his team work…

Jim serves as Executive Vice President and Chief Product and Innovation Officer for newly formed Vyaire Medical in Mettawa, IL. In his role, Jim is responsible for marketing and research and development and managing the full product innovation cycle. Jim has spent over twenty years in the medical device industry, serving most recently as the…

Benjamin Kramer, MD is the Vice President, Medical Affairs for Immunology and Ophthalmology at Genentech. He has worked for nearly 20 years in the pharmaceutical industry, with significant leadership experience in both global clinical development and global medical affairs in respiratory, urology and immunology. Ben came to Genentech in 2012 from Novartis, where he acted…

Jimmy Rosen is Managing Partner of Three Lakes Partners, a Venture Philanthropy on a mission to end Idiopathic Pulmonary Fibrosis (IPF). Three Lakes Partners is attacking IPF from all sides: diagnosis, treatment, patient quality of life, research, and funding all by engaging the most innovative, aggressive and experienced partners in their fight against IPF. Jimmy…